AI-driven biomanufacturing scale‑up

Synthetic biology is rapidly transforming industrial manufacturing by engineering microbes to produce sustainable alternatives to plastics, textiles and chemicals. Analysts value the emerging sector at roughly $14 billion, noting that bio‑fabricated materials can be up to 20 % stronger than conventional synthetics while being fully biodegradable and generating significantly lower carbon emissions.

Research teams at KAIST have highlighted the “valley of death” that separates laboratory breakthroughs from commercial production. Their AI‑based roadmap proposes a phased market entry, beginning with high‑value applications such as pharmaceuticals, cosmetics and food ingredients before expanding to broader uses. AI tools—including enzyme and microbial design, digital‑twin process simulations, and integrated economic‑environmental analysis—are expected to shorten development cycles, cut costs and improve competitiveness, accelerating the shift from petroleum‑based chemicals to a greener bio‑economy.